Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
290 hedge funds and large institutions have $1.7B invested in Avanos Medical in 2019 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 67 increasing their positions, 80 reducing their positions, and 53 closing their positions.
98% more call options, than puts
Call options by funds: $2.02M | Put options by funds: $1.02M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.6% less ownership
Funds ownership: 95.47% → 94.86% (-0.6%)
9% less funds holding
Funds holding: 317 → 290 (-27)
14% less capital invested
Capital invested by funds: $1.98B → $1.7B (-$282M)
16% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 80
47% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 53
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$17.6M |
| 2 |
RC
RGM Capital
Naples,
Florida
|
+$17.6M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$12M |
| 4 |
PIM
Paradice Investment Management
Denver,
Colorado
|
+$9.79M |
| 5 |
MIH
Madison Investment Holdings
Madison,
Wisconsin
|
+$5.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCP
Sandhill Capital Partners
Buffalo,
New York
|
-$17.3M |
| 2 |
Select Equity Group
New York
|
-$15.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$14.1M |
| 4 |
State Street
Boston,
Massachusetts
|
-$5.91M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$5.52M |
AVNS Hedge Fund Activity: Q3 2019 in Review
290 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q3 2019, worth a combined $1.7B — down 14% from $1.98B a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of AVNS and 28 opened new positions — a net loss of 25 holders — while 80 trimmed existing stakes and 67 added.
The largest buyer was Wellington Management Group, adding an estimated $17.6M. The largest seller was Sandhill Capital Partners, exiting entirely with an estimated $17.3M sold.
- 290 institutional investors held Avanos Medical (AVNS) as of Q3 2019, down from 317 in Q2 2019.
- Funds reported $1.7B of Avanos Medical stock for Q3 2019, down 14% quarter-over-quarter.
- 28 funds opened new Avanos Medical positions in Q3 2019 and 53 closed out, a net change of -25 holders.
- The largest Avanos Medical buyer in Q3 2019 was Wellington Management Group, an estimated $17.6M added.
- The largest Avanos Medical seller in Q3 2019 was Sandhill Capital Partners, an estimated $17.3M sold.
Based on aggregated 13F filings for Q3 2019.